Works matching IS 02698811 AND DT 2011 AND VI 25 AND IP 3


Results: 22
    1
    2
    3
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Preclinical and clinical pharmacology of TPA023B, a GABAA receptor α2/α3 subtype-selective partial agonist.

    Published in:
    Journal of Psychopharmacology, 2011, v. 25, n. 3, p. 329, doi. 10.1177/0269881109354928
    By:
    • Atack, J. R.;
    • Hallett, D. J.;
    • Ye, S. T.;
    • Wafford, K. A.;
    • Ryan, C.;
    • Sanabria-Bohórquez, S. M.;
    • Eng, Wai-si;
    • Gibson, R. E.;
    • Burns, H. D.;
    • Dawson, G. R.;
    • Carling, R. W.;
    • Street, L. J.;
    • Pike, A.;
    • De Lepeleire, I.;
    • Laere, K. Van;
    • Bormans, G.;
    • De Hoon, J. N.;
    • Hecken, A. Van;
    • McKernan, R. M.;
    • Murphy, M. G.
    Publication type:
    Article
    17

    MRK-409 (MK-0343), a GABAA receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humans.

    Published in:
    Journal of Psychopharmacology, 2011, v. 25, n. 3, p. 314, doi. 10.1177/0269881109354927
    By:
    • Atack, Jop J. R.;
    • Wafford, K. A.;
    • Street, L. J.;
    • Dawson, G. R.;
    • Tye, S.;
    • Laere, K. Van;
    • Bormans, G.;
    • Sanabria-Bohórquez, S. M.;
    • De Lepeleire, I.;
    • De Hoon, J. N.;
    • Hecken, A. Van;
    • Burns, H. D.;
    • McKernan, R. M.;
    • Murphy, M. G.;
    • Hargreaves, R. J.
    Publication type:
    Article
    18
    19
    20
    21
    22